SMI DRUG DISCOVERY LIMITED
SMI DRUG DISCOVERY LIMITED is a private limited company registered in the United Kingdom, under 11175710, incorporated on 29 January 2018. The company is currently active. Operates in the research and experimental development on biotechnology sector (SIC 72110). The company has been operating for 8 years. Registered office address: CB25 9HA Cambridge, the United Kingdom. Directors include MR STEPHEN LITTLE, DR JOHN HIRST, and DR ANDREW JAMES THOMPSON, and 2 others. Sole shareholder is NORCLIFFE NOMINEES LIMITED. Associated with 4 related entities, including BIOXHALE LTD, WIFI SECURITIES LIMITED, and 13978654. The overall risk score is 0/100 (negligible). Confirmation statement next due 2026-01-20, overdue as of 2026-03-02. Data sourced from UK Companies House.
Official Identifiers
Registered Address
23 LONGMEADOW
LODE
CB25 9HA CAMBRIDGE
the United Kingdom
Entity Risk Evaluation
Signal Intelligence (1)
| Type | Severity | Description | Detected |
|---|---|---|---|
| confirmation statement overdue | MEDIUM | Confirmation statement next due 2026-01-20, overdue as of 2026-03-02 | — |
Key Management & Controllers
Associated Entities
Companies sharing one or more directors or officers with this entity.
Change Log (5)
| Date | Change | Details |
|---|---|---|
| 2026-05-01 | DIRECTOR ADDED | Dr Andrew James Thompson (director) |
| 2026-05-01 | DIRECTOR ADDED | Stephen Little (director) |
| 2026-05-01 | DIRECTOR ADDED | Dr John Hirst (director) |
| 2026-05-01 | DIRECTOR ADDED | James John Clark (director) |
| 2026-05-01 | DIRECTOR ADDED | Ronald Andrews (director) |
Source Records (1)
| companieshouse | 11175710 | 2026-06-01 | open_in_new |